Nonlinear progression during the occult transition establishes cancer lethality
Disease Models & Mechanisms · 01.03.2025 · 18 (3)
DOI: 10.1242/dmm.052113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 19.03.2025. Verfasst von Joshua D Ginzel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Duke University, Durham, NC 27710, USA. Hauptthemen laut MEDLINE: Disease Progression, Nonlinear Dynamics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Duke University, U.S. Department of Defense.
Abstract (Originalsprache)
Cancer screening relies upon a linear model of neoplastic growth and progression. Yet, historical observations suggest that malignant progression is uncoupled from growth, which may explain the paradoxical increase in early-stage breast cancer detection without a dramatic reduction in metastasis. Here, we lineage trace millions of transformed cells and thousands of tumors using a cancer rainbow mouse model of HER2 (also known as ERBB2)-positive breast cancer. Transition rates from field cell to screen-detectable tumor to symptomatic tumor were estimated from a dynamical model of tumor development. Field cells were orders of magnitude less likely to transition to a screen-detectable tumor than the subsequent transition from screen-detectable tumor to symptomatic tumor. Our model supports a critical ‘occult’ transition in tumor development during which a transformed cell becomes a bona fide neoplasm. Lineage tracing and test by transplantation revealed that nonlinear progression during the occult transition gives rise to nascent lethal cancers at screen detection. Simulations illustrated how occult transition rates are a critical determinant of tumor growth and malignancy. Our data provide direct experimental evidence that cancers can deviate from the predictable linear progression model that is foundational to current screening paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Duke University, Durham, NC 27710, USA.
- Department of Cell Biology, Duke University, Durham, NC 27710, USA.
- Department of Pathology and Laboratory Medicine, UC Davis, Davis, CA 95817, USA.
- Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA.
ORCID-Profile: Joshua D Ginzel, Robert D Cardiff, Alexander D Borowsky, Herbert Kim Lyerly, Bruce W Rogers, Joshua C Snyder
Förderung
- NCI NIH HHS
- Duke University
- U.S. Department of Defense
- National Cancer Institute
Zitieren
APA
Ginzel, J. D., Chapman, H., Sills, J. E., Allen, E. J., Barak, L. S., Cardiff, R. D., Borowsky, A. D., Lyerly, H. K., Rogers, B. W., & Snyder, J. C. (2025). Nonlinear progression during the occult transition establishes cancer lethality. Disease Models & Mechanisms, 18(3). https://doi.org/10.1242/dmm.052113
Vancouver
Ginzel JD, Chapman H, Sills JE, Allen EJ, Barak LS, Cardiff RD, et al. Nonlinear progression during the occult transition establishes cancer lethality. Disease Models & Mechanisms. 2025;18(3). doi:10.1242/dmm.052113
BibTeX
@article{Ginzel2025,
author = {Ginzel, Joshua D and Chapman, Henry and Sills, Joelle E and Allen, Edwin J and Barak, Lawrence S and Cardiff, Robert D and Borowsky, Alexander D and Lyerly, Herbert Kim and Rogers, Bruce W and Snyder, Joshua C},
title = {Nonlinear progression during the occult transition establishes cancer lethality},
journal = {Disease Models & Mechanisms},
year = {2025},
volume = {18},
number = {3},
doi = {10.1242/dmm.052113}
}
EUVIMED